Onkologie. 2011:5(5):283-284

Concomitant chemoradiotherapy for rectal carcinoma

Luboš Holubec, Tomáš Svoboda, Jindřich Fínek
Onkologické a radioterapeutické oddělení, FN Plzeň

In recent years, there have been changes in approaching the treatment for rectal carcinoma. The treatment for rectal carcinoma is an

example of a comprehensive multimodal therapy which includes surgery, radiotherapy, chemotherapy or concomitant chemoradiotherapy.

The authors summarize the existing knowledge and recommendations for concomitant chemoradiotherapy of the rectum.

Keywords: rectal carcinoma, chemotherapy, radiotherapy, concomitant chemoradiotherapy

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holubec L, Svoboda T, Fínek J. Concomitant chemoradiotherapy for rectal carcinoma. Onkologie. 2011;5(5):283-284.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Glimelius B, Pahlman L, Cervantes A. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2010; 21(5): 82-86. Go to original source... Go to PubMed...
    2. Lovas P, Lovasová Z. Adjuvantní terapie u karcinomu rekta. Klin Onkol 2011; 24(2): 94-100. Go to PubMed...
    3. Diviš P, Vlček P, Čapov I, Divišová K, Katolická J, Vaníček J, Kotulánová E. Hodnocení neoadjuvantní chemoradioterapie u lokálně pokročilého karcinomu rekta srovnáním objemu tumoru před léčbou a po léčbě. Klin Onkol 2010; 23(6): 421-427. Go to PubMed...
    4. Šlampa P, Lovas P, Lovasová Z, a kol. Konkomitantní chemoradioterapie solidních nádorů. Postgradiální medicína 2009; 11: 153-160.
    5. Kiss I, Tomášek J, Robek O, a kol. Karcinom tlustého střeva, konečníku a anu. In: Jurga LM. Klinická a radiačná onkológia. Martin: Osveta 2010: 938-948.
    6. Wolmark N, Wieand H, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: NSABP protocol R-02. J. Natl Cancer I 2000; 5: 388-396. Go to original source... Go to PubMed...
    7. National Comprehensive Cancer Network, NCCN Clinical Practice Guidelinesin Oncology: Rectal cancer 2011; 4, USA http://www.nccn.com.
    8. Smalley SR, Benedetti JK, Williamson SK, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006; 24(22): 3542-3547. Go to original source... Go to PubMed...
    9. Novotný J, Vítek P, Šafanda M. Karcinom tračníku a rektosigmatu. In: Novotný J. Klinická a radiační onkologie pro praxi. Praha: Triton 2005: 68-83.
    10. Vysloužil K. Terapie maligního nádoru rekta. In: Vysloužil K, Cwiertka K. Komplexní léčba nádorů rekta. Praha: Grada 2005: 43-122.
    11. Sun XN, Yang QC, Hu JB. Pre-operative radiochemotherapy of locally advanced rectal cancer. J Gastroenterol 2003; 9(4): 717-720. Go to original source... Go to PubMed...
    12. Moser L, Ritz JP, Hinkelbein W, Hochst S. Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancor - a review focusing on open questions. Int J Colorectal Dis 2008; 23(3): 227-236. Go to original source... Go to PubMed...
    13. Bosser JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355(11): 1114-1123. Go to original source... Go to PubMed...
    14. Fisher B, Wolmark N, Rockette H, et al. Adjuvant chemotherapy or post-operative radiation for rectal cancer: 5 year results of NASBP protocol R-01. Am Soc Clin Oncol 1987; 6(A): 359-392.
    15. Krook JE, Moertel CG, Gunderson LL. Effective surgical adjuvant therapy for high - risk rectal carcinoma. N Engl J Med 1991; 324(11): 709-715. Go to original source... Go to PubMed...
    16. Schmoll HJ, Cartwright T, Tabernero J, et al. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol 2007; 25(1): 102-109. Go to original source... Go to PubMed...
    17. Minsky BD, Guillem JG. Multidisciplinary management of resectable rectal cancer. New developments and controversies. Oncology (Williston Park) 2008; 22(12): 1430-1437. Go to PubMed...
    18. Kachnic LA. Adjuvant chemoradiation for localized rectal cancer: current trends and future directions. Gastrointest Cancer Res 2007; 1(4, Suppl 2): 64-72.
    19. Hong TS, Kachnic LA. Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard. Gastrointest Cancer Res. 2007; 1(2): 49-56.
    20. Kachnic LA. Should preoperative or postoperative therapy be administered in the management of rectal cancer? Semin Oncol 2006; 33(6, Suppl 11): 64-69. Go to original source... Go to PubMed...
    21. Bujko K, Kepka L, Michalski W, Nowacki MP. Does rectal cancer shrinkage induced by preoperative radio (chemo) therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol. 2006; 80(1): 4-12. Go to original source... Go to PubMed...
    22. Valentini V, Valvo F, Cellini N. [Simultaneous radiochemotherapy in rectal tumors]. Ann Ital Chir 2001; 72(5): 557-566. Go to PubMed...
    23. Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, Bardet E, Pierart M, Briffaux A. EORTC Radiotherapy Group. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004; 40(2): 219-224. Go to original source... Go to PubMed...
    24. Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol. 2005; 23(24): 5620-5627. Go to original source... Go to PubMed...
    25. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006 Sep 14; 355 (11): 1114-23. Erratum in: N Engl J Med 2007; 357(7): 728. Go to original source... Go to PubMed...
    26. Den Dulk M, Collette L, Van de Velde CJ, Marijnen CA, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bosset JF. EORTC Radiation Oncology Group. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer 2007; 43(12): 1821-1828. Go to original source... Go to PubMed...
    27. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004 Oct 21; 351(17): 1731-1740. Go to original source... Go to PubMed...
    28. Fietkau R, Rödel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, Karstens J, Ewald H, Christen N, Jagoditsch M, Martus P, Sauer R. German Rectal Cancer Study Group. Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys 2007; 67(4): 1008-1019. Go to original source... Go to PubMed...
    29. Sauer R, Fietkau R, Wittekind C, Rödel C, Martus P, Hohenberger W, Tschmelitsch J, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R. German Rectal Cancer Group. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis. 2003; 5(5): 406-415. Go to original source... Go to PubMed...
    30. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SROV, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
    31. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 2006; 66(5): 1378-1383. Go to original source... Go to PubMed...
    32. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Gastrointest Cancer Res 2007; 1(2): 44-48.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.